From 1 st January to 31 st December 2014 27 institutions around Australia participated in the Australian Enterococcal Sepsis Outcome Programme (AESOP). The aim of AESOP 2014 was to determine the proportion of enterococcal bacteraemia isolates in Australia that were antimicrobial resistant, and to characterise the molecular epidemiology of the E. faecium isolates. Of the 952 unique episodes of bacteraemia investigated, 94.8% were caused by either E. faecalis (54.9%) or E. faecium (39.9%). Ampicillin resistance was detected in 0.6% of E. faecalis and in 90.5% of E. faecium. Vancomycin non-susceptibility was reported in 0.2% and 46.1% of E. faecalis and E. faecium respectively. Overall 50.1% of E. faecium harboured vanA or vanB genes. For the vanA/B positive E. faecium isolates, 81.2% harboured vanB genes and 18.8 % vanA
genes.
The percentage of E. faecium bacteraemia isolates resistant to vancomycin in Australia is significantly higher than that seen in most European countries. E. faecium consisted of 113 PFGE pulsotypes of which 68.9% of isolates were classified into 14 major pulsotypes containing five or more isolates.
Multilocus sequence typing grouped the 14 
Background
Globally enterococci are thought to account for approximately 10% of all bacteraemias, and in North America and Europe is the fourth and fifth leading cause of sepsis respectively. 1,2 Although in the 1970s healthcare-associated enterococcal infections were primarily due to Enterococcus faecalis, there has been a steadily increasing prevalence of E. faecium nosocomial infections. [3] [4] [5] Worldwide the increase in nosocomial E. faecium The Australian Group on Antimicrobial Resistance (AGAR) is a network of laboratories located across Australia that commenced surveillance of antimicrobial resistance in Enterococcus species in 1995. 7 In 2011 AGAR commenced the Australian Enterococcal Sepsis Outcome Programme (AESOP). 8 The objective of AESOP 2014 was to determine the proportion of E.
faecalis and E. faecium bacteraemia isolates demonstrating antimicrobial resistance with particular emphasis on: Approval to conduct the prospective data collection was given by the research ethics committee associated with each participating laboratory.
Results
From 1 The majority of Efm85 -ST80 isolates harboured vanA genes.
Conclusions
The AESOP 2014 study has shown that although predominately caused by E. faecalis, enterococcal bacteraemia in Australia is frequently caused by ampicillinresistant high-level gentamicin-resistant vanB E. faecium. Furthermore the percentage of E. faecium bacteraemia isolates resistant to vancomycin in Australia is significantly higher than that seen in almost all European countries.
Although the vanB operon continues to be the predominant genotype, the number of vanA E. faecium identified in AESOP 2014 has significantly increased when compared to AESOP 2013. In addition to being a significant cause of healthcare-associated sepsis, the emergence of multiple multi-resistant hospitaladapted E. faecium strains has become a major infection control issue in Australian hospitals. Further studies on the enterococcal genome will contribute to our understanding of the rapid and ongoing evolution of enterococci in the hospital environment and assist in preventing their nosocomial transmission. 
